JAMA Network Home
Sign In
Research Letter

Potential Impact of Next-Generation Weight Loss Drugs on Cancer Incidence

JAMA Network Open 10.1001/jamanetworkopen.2025.30904

September 08, 2025 at 11:00 AM EDT

Read the full article

This decision analytical model projects changes in obesity-related cancer incidence among US adults following the potential impact of glucagon-like peptide 1 receptor agonists on weight loss.

Corresponding Author: Darren R. Brenner, PhD, Department of Oncology, Alberta Health Services, 3330 Hospital Dr NW, Calgary, AB T2N 4N1, Canada (darren.brenner@ucalgary.ca).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.30904?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090825

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks